InnovAge Holding Corp. (INNV) - Stock Analysis

Last updated: Apr 4, 2026

HealthcareClosed

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

InnovAge (INNV) demonstrates strong operational turnaround with positive adjusted EBITDA, expanding participant base, joint ventures for growth, and robust technical momentum with a 47% stock increase over a month. Its sustainable earnings and strategic partnerships support near-term appreciation potential in healthcare services.

Loading chart data...

Idea window: 2/5/2026 – 2/12/2026Sector: Healthcare

AI Analyst Overview

Last Price
$8.49
Market Cap
$1.15B
1D Return
+1.68%
YTD Return
+63.58%

Loading chart data...

Valuation Metrics

P/E
-279.7
P/B
4.5
P/S
1.3
EV/EBITDA
47.4
Div Yield
—

Fundamental Analysis

6.0

Key Financial Insights: • Improving liquidity • Thin net margins • Elevated leverage INNV has turned to quarter-level profitability with stronger liquidity and cash generation but still suffers thin margins, high payables and elevated valuation multiples that leave limited downside cushion.

ImprovingCash
HighMultiples

Price Behavior

5.0

Key Price Behavior Insights: • Below last month average • Recent 20% drop • High short-term volatility Support Level: $7.60 Resistance Level: $8.70–$9.50 Price is in a clear downtrend (≈20% lower since early March) trading below its last month average (~$8.30) with near-term support around $7.6 and resistance bands at $8.7 and $9.5, signaling bearish momentum but a clear bullish reversal if price holds above $8.7–$9.5.

bearish
watch

Sentiment & News

6.0

Key News Insights: • Technical support • Earnings upgrades • Repeated buy-list March headlines show growing optimism for InnovAge—technical support, upward earnings revisions and multiple Zacks Strong Buy inclusions point to an improved earnings outlook and stronger industry positioning.

StrongBuy
DigitalHealth
AI

AI Summary

6.0
Neutral

InnovAge has shifted from a turnaround story to demonstrable operational recovery—revenue acceleration, positive quarterly net income and FCF with a clear path to mid-single-digit adjusted EBITDA—but the stock still trades like a perfection-priced growth name vulnerable to Medicaid/MA policy swings, execution on pharmacy insourcing/de novo discipline, and member-months stability, so investors should watch member-month guidance, pharmacy savings realization, and redetermination trends over the next 12–18 months.

Recovery
PolicyRisk
Execution
AI summary updated 5 days ago

Description

InnovAge Holding Corp. operates a Program of All-Inclusive Care for the Elderly (PACE) model, delivering both in-home and center-based medical and support services for seniors who require assistance to remain in their communities. The company serves about 6,850 participants through 18 centers across Colorado, California, New Mexico, Pennsylvania and Virginia, and offers care management, skilled and personal care, therapy, dental and mental health services, meals and transportation. Founded in 2007 and headquartered in Denver, it adopted the InnovAge name in January 2021.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Feb 5Feb 12INNVInnovAge Holding Corp.
InnovAge (INNV) demonstrates strong operational turnaround with positive adjusted EBITDA, expanding participant base, joint ventures for growth, and robust technical momentum with a 47% stock increase over a month. Its sustainable earnings and strategic partnerships support near-term appreciation potential in healthcare services.
Closed+11.8%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.